Imax Q2 2024 GAAP EPS $0.07, Inline, Sales $89.00M Beat $76.01M Estimate
Portfolio Pulse from Benzinga Newsdesk
Imax (NYSE:IMAX) reported Q2 2024 GAAP EPS of $0.07, meeting analyst expectations. The company achieved sales of $89.00 million, surpassing the $76.01 million estimate by 17.09%, despite a 9.16% year-over-year decline.
July 25, 2024 | 11:31 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Imax reported Q2 2024 GAAP EPS of $0.07, in line with expectations, and sales of $89.00 million, beating estimates by 17.09%. However, sales declined by 9.16% year-over-year.
The earnings per share met expectations, which is neutral news. However, the significant beat on sales estimates by 17.09% is positive and likely to boost investor confidence in the short term. The year-over-year decline in sales is a negative factor but is outweighed by the strong performance against estimates.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100